1. Home
  2. Catalog
  3. Retatrutide
PEPTAURA
  1. Home
  2. Catalog
  3. Retatrutide
HomeCatalogSuppliersCOAsShippingVerify

Site Map

HomeCatalogRFQFAQVerifySuppliersCOAsBecome an AffiliateSellers PortalContact

Legal

DisclaimersPrivacy Policy

© 2026 peptaura.com, All Rights Reserved.

RETATRUTIDE

Dose per Vial/Cartridge

Latest Research

Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies.

2026 Jun

Lempesis IG, Dalamaga M

Open

Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.

2026 Apr 10

Li Q, Cheng W, Zhang J, Ran S, Yu H, Zhou W, Wang Y, Lin J, Liu Y, Hong X, Li H, Yan S

Open

Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.

2026 Apr

Lian J, Lareu RR, Patil M, Falasca M

Open

Efficacy of GLP-1 analog peptides, semaglutide, tirzepatide, and retatrutide on MC4R deficient obesity and their comparison.

2026 Apr

Hitaka K, Sugawara T, Matsumoto M, Nio Y

Open

Childhood Obesity and Cardiac Risk in Youth: Emerging Challenges Toward 2050.

2026 Mar 31

Mishra NK

Open

New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication.

2026 Mar 18

Pardali EC, Gkouskou KK, Cholevas C, Poulimeneas D, Tsiroukidou K, Goulis DG, Grammatikopoulou MG

Open

Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes.

2026 Mar 14

Malandris K, Charalampidis K, Loomba R, Sinakos E

Open

Retatrutide in type 2 diabetes mellitus and obesity: an overview.

2026 Mar 10

Panou T, Gouveri E, Popovic DS, Papanas N

Open

Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials.

2026 Mar

Abulehia A, Ayesh H, Ayesh O, Jaber D, Asad T, Itbaisha A, Abugharbieh H, Gharbia R, Abu-Hilal LH, Leon BGC

Open

Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.

2026 Feb 25

Briand F, Le Cudennec C, Grasset E, Breyner N, Bigot C, Dillard P, Sulpice T

Open